Skip to main content
. 2022 Jan 3;13(1):1399–1410. doi: 10.1080/21655979.2021.2017700

Figure 1.

Figure 1.

DEZ treatment elevated the viability of HNPCs after IL-1β exposure. (a) The chemical structure of DEZ. (b) Cell viability was examined with a CCK-8 assay after HNPCs treatment with different concentrations (0.5, 1, 2, 4 and 8 μg/mL) of DEZ. *P < 0.05 vs. 0 μg/mL. (c) Cell viability was determined with a CCK-8 assay when HNPCs were exposed to 0.5, 1 and 2 μg/mL DEZ under IL-1β stimulated condition. ***P < 0.001 vs. untreated group; #P < 0.05, ###P < 0.001 vs. IL-1β group.